Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 3 | 2019 | 233 | 1.220 |
Why?
|
| Hippocampus | 5 | 2017 | 915 | 0.880 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2011 | 39 | 0.700 |
Why?
|
| Fear | 3 | 2017 | 254 | 0.690 |
Why?
|
| Stereotyped Behavior | 1 | 2019 | 35 | 0.690 |
Why?
|
| Diet, Ketogenic | 1 | 2019 | 22 | 0.680 |
Why?
|
| Fragile X Syndrome | 2 | 2017 | 150 | 0.660 |
Why?
|
| Diet Therapy | 1 | 2019 | 52 | 0.650 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2016 | 19 | 0.590 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2016 | 46 | 0.580 |
Why?
|
| Estradiol | 2 | 2016 | 748 | 0.560 |
Why?
|
| Motor Activity | 2 | 2019 | 693 | 0.530 |
Why?
|
| Learning | 2 | 2017 | 403 | 0.500 |
Why?
|
| Cocaine-Related Disorders | 1 | 2016 | 231 | 0.480 |
Why?
|
| Epilepsy | 1 | 2021 | 883 | 0.460 |
Why?
|
| Neuropeptides | 1 | 2011 | 154 | 0.370 |
Why?
|
| Neuronal Plasticity | 2 | 2011 | 304 | 0.350 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2017 | 107 | 0.340 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2009 | 259 | 0.320 |
Why?
|
| Association Learning | 1 | 2007 | 28 | 0.300 |
Why?
|
| Avoidance Learning | 1 | 2007 | 94 | 0.290 |
Why?
|
| Nucleus Accumbens | 2 | 2016 | 61 | 0.280 |
Why?
|
| Aminoquinolines | 3 | 2017 | 46 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 2063 | 0.250 |
Why?
|
| Long-Term Potentiation | 2 | 2017 | 176 | 0.210 |
Why?
|
| Growth Substances | 1 | 2002 | 300 | 0.200 |
Why?
|
| Memory | 3 | 2017 | 429 | 0.200 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2002 | 342 | 0.190 |
Why?
|
| Cyclins | 1 | 2002 | 456 | 0.190 |
Why?
|
| Angelman Syndrome | 1 | 2021 | 78 | 0.190 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2019 | 32 | 0.170 |
Why?
|
| Fragile X Mental Retardation Protein | 2 | 2017 | 126 | 0.170 |
Why?
|
| Metabolism | 1 | 2019 | 55 | 0.170 |
Why?
|
| Behavior, Animal | 3 | 2019 | 709 | 0.160 |
Why?
|
| Ovariectomy | 2 | 2016 | 330 | 0.160 |
Why?
|
| Prepulse Inhibition | 1 | 2017 | 5 | 0.160 |
Why?
|
| Reflex, Acoustic | 1 | 2017 | 7 | 0.160 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2016 | 151 | 0.160 |
Why?
|
| Theta Rhythm | 1 | 2017 | 29 | 0.160 |
Why?
|
| Reflex, Startle | 1 | 2017 | 65 | 0.150 |
Why?
|
| Dopamine | 1 | 2019 | 312 | 0.150 |
Why?
|
| Self Administration | 1 | 2016 | 50 | 0.150 |
Why?
|
| Conditioning, Operant | 1 | 2016 | 48 | 0.150 |
Why?
|
| Endocannabinoids | 1 | 2016 | 21 | 0.140 |
Why?
|
| Models, Animal | 1 | 2019 | 664 | 0.140 |
Why?
|
| Animals | 10 | 2021 | 59536 | 0.140 |
Why?
|
| Rats | 3 | 2021 | 6086 | 0.130 |
Why?
|
| Dendritic Spines | 2 | 2016 | 59 | 0.130 |
Why?
|
| Behavior, Addictive | 1 | 2016 | 99 | 0.130 |
Why?
|
| DNA Damage | 1 | 2002 | 1954 | 0.120 |
Why?
|
| Body Weight | 1 | 2019 | 1293 | 0.120 |
Why?
|
| Pyrimidines | 3 | 2017 | 3518 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2016 | 417 | 0.120 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2011 | 245 | 0.110 |
Why?
|
| Phenotype | 2 | 2021 | 6295 | 0.110 |
Why?
|
| Estrogens | 1 | 2016 | 751 | 0.110 |
Why?
|
| Pyrones | 1 | 2011 | 10 | 0.100 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2011 | 43 | 0.100 |
Why?
|
| Dizocilpine Maleate | 1 | 2009 | 21 | 0.090 |
Why?
|
| Dendrites | 1 | 2011 | 196 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2017 | 5710 | 0.090 |
Why?
|
| Pyridines | 1 | 2016 | 1244 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2011 | 2307 | 0.090 |
Why?
|
| Raptors | 1 | 2008 | 5 | 0.090 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2008 | 22 | 0.090 |
Why?
|
| Pain | 1 | 2017 | 1658 | 0.080 |
Why?
|
| Apoptosis | 1 | 2002 | 7591 | 0.080 |
Why?
|
| Quinolines | 1 | 2011 | 383 | 0.080 |
Why?
|
| Synapses | 1 | 2011 | 509 | 0.070 |
Why?
|
| Environment | 1 | 2007 | 190 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2011 | 6942 | 0.070 |
Why?
|
| Mice | 6 | 2021 | 34495 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 5767 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2008 | 874 | 0.060 |
Why?
|
| Neurons | 3 | 2011 | 2287 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 94 | 0.050 |
Why?
|
| Male | 4 | 2019 | 123000 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 528 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 324 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 7222 | 0.050 |
Why?
|
| Time Factors | 2 | 2011 | 12926 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2002 | 726 | 0.040 |
Why?
|
| Female | 3 | 2019 | 141928 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2011 | 1618 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2021 | 898 | 0.040 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2016 | 33 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2002 | 2084 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1493 | 0.030 |
Why?
|
| Cell Survival | 1 | 2002 | 3045 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 1442 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 854 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2002 | 3005 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 989 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 5395 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2011 | 11965 | 0.030 |
Why?
|
| Silver Staining | 1 | 2011 | 14 | 0.030 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2011 | 24 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 1035 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 388 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2011 | 426 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 3552 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 2009 | 102 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 106 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 4053 | 0.020 |
Why?
|
| Maze Learning | 1 | 2008 | 132 | 0.020 |
Why?
|
| Humans | 2 | 2021 | 261506 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 184 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2016 | 1471 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2009 | 369 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 443 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 889 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1338 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 4143 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 1546 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 1879 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 4804 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 3254 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 4113 | 0.010 |
Why?
|